A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung Cancer.
Aggarwal C, Maity AP, Bauml JM, Long Q, Aleman T, Ciunci C, D'Avella C, Volpe M, Anderson E, Jones LM, Sun L, Singh AP, Marmarelis ME, Cohen RB, Langer CJ, Amaravadi R.
Aggarwal C, et al. Among authors: sun l.
Oncologist. 2023 Jul 5;28(7):644-e564. doi: 10.1093/oncolo/oyad106.
Oncologist. 2023.
PMID: 37186063
Free PMC article.
Clinical Trial.